Rigel Pharmaceuticals Inc.

(RIGL) Trade

By |

Profile

Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's lead drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken over all responsibility to develop and market the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes Fostamatinib - ITP, Fostamatinib - AIHA, Fostamatinib - IgAN, BGB324 - Oral AXL Inhibitor, ATI-50001 & 50002 - JAK Inhibitors, DS-3032-MDM2 Inhibitor, THF-beta Inhibitors and AZD0449- Inhaled JAK Inhibitor.

Contact Information

Website: www.rigel.com
Email: ir@rigel.com
Main Phone: +1 650 624-1100
Address: 1180 Veterans Boulevard
State: CA
City / Town: South San Francisco
Country: USA
Postal Code: 94080

Issuer Information

Exchange: NGS
CEO: Raul R. Rodriguez
Employees: 103
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 2.85 $ 0.09 (3.26%)
Last Price 2.85 Change $ 0.09 Change % 3.26 Tick N/A
Bid 2.75 Bid Size 200.00 Ask 2.93 Ask Size 3,900.00
Open 2.80 High 2.91 Low 2.79 Prev Close 2.76
Last Trade Volume 1.3 mi 52 Wk Hi 4.71 52 Wk Low 2.56
Market Cap 474.9 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 166,640,472.00 EPS (TTM) -0.66 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 1 4
Number of Buys 0 1
Number of Sells 1 3
Net Activity -5000 -10000
Last 10 Buys Shares
N/A 0
Last 10 Sell Shares
Anne-Marie Duliege 1,000
Ryan D. Maynard 1,000
Anne-Marie Duliege 1,000
Anne-Marie Duliege 1,000
Donald G. Payan 1,000
Donald G. Payan 1,000
Dolly A. Vance 1,000
Donald G. Payan 1,000
Dolly A. Vance 1,000
Ryan D. Maynard 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 10 10 10 10
Low Target Price Estimate 6 6 6 6
Mean Target Price Estimate 7.92 7.92 7.92 7.92
Standard Deviation 1.43 1.43 1.43 1.43
Date of Most Recent Estimate 05/22/18 05/22/18 05/22/18 05/22/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 6 6 5 5
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1